Company Registration No. 08804774 (England and Wales)
Neubourg Pharma (UK) Limited
Unaudited accounts
for the year ended 31 December 2023
Neubourg Pharma (UK) Limited
Unaudited accounts
Contents
Neubourg Pharma (UK) Limited
Company Information
for the year ended 31 December 2023
Directors
Mr G McGlynn
Mr T Neubourg
Company Number
08804774 (England and Wales)
Registered Office
75 SPRINGFIELD ROAD
CHELMSFORD
ESSEX
CM2 6JB
ENGLAND
Accountants
Harden & Co Chartered Certified Accountants
Maelstrom House
Taylors Hill
Chilham
Kent
CT4 8BZ
Neubourg Pharma (UK) Limited
Statement of financial position
as at 31 December 2023
Cash at bank and in hand
77
5,688
Creditors: amounts falling due within one year
(144,942)
(145,375)
Net current liabilities
(144,865)
(139,687)
Net liabilities
(144,820)
(139,627)
Called up share capital
100
100
Share premium
239,900
239,900
Profit and loss account
(384,820)
(379,627)
Shareholders' funds
(144,820)
(139,627)
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 10 April 2024 and were signed on its behalf by
Mr G McGlynn
Director
Company Registration No. 08804774
Neubourg Pharma (UK) Limited
Notes to the Accounts
for the year ended 31 December 2023
Neubourg Pharma (UK) Limited is a private company, limited by shares, registered in England and Wales, registration number 08804774. The registered office is 75 SPRINGFIELD ROAD, CHELMSFORD, ESSEX, CM2 6JB, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% reducing balance
These Accounts have been prepared on a going concern basis as the directors have given an assurance that the company will be supported as needed by directors' loans.
4
Tangible fixed assets
Computer equipment
Neubourg Pharma (UK) Limited
Notes to the Accounts
for the year ended 31 December 2023
5
Creditors: amounts falling due within one year
2023
2022
Taxes and social security
-
14,441
Loans from directors
142,292
129,584
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
7
Average number of employees
During the year the average number of employees was 1 (2022: 1).